|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.8 USD | +4.53% |
|
+33.78% | +230.00% |
| 07-15 | Second malaria vaccine launched in Ivory Coast in new milestone | RE |
| 07-02 | Novavax Seeks Health Canada Approval for Updated Covid-19 Vaccine | MT |
NOVAVAX SAYS COVID-19 VACCINE CANDIDATE NVX-COV2373 MET PRIMARY ENDPOINT, WITH VACCINE EFFICACY OF 89.3%, IN PHASE 3 CLINICAL TRIAL CONDUCTED IN UK
| 1st Jan change | Capi. | |
|---|---|---|
| +230.00% | 2.12B | |
| +24.83% | 46.56B | |
| +45.38% | 41.67B | |
| +0.13% | 41.16B | |
| +33.82% | 32.4B | |
| +20.56% | 28.18B | |
| -6.35% | 28.1B | |
| +49.20% | 14.52B | |
| +47.27% | 13.74B | |
| +2.55% | 12.17B |
NOVAVAX, INC. 
